© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Indomethacin stands as a nonsteroidal anti-inflammatory drug, mainly used to reduce pain, swelling, and stiffness from a range of conditions, like arthritis and gout. Its structure features a classic fused indole ring system, which ties back to its anti-inflammatory performance. The chemical is solid at room temperature, showing up most often as either a white or pale yellow crystalline powder. On rare occasions, one may come across it as flakes, though less commonly than as powder or solid tablets. Its composition brings with it both clinical potential and safety challenges, drawing attention to its handling and application in manufacturing and healthcare settings.
Indomethacin’s molecular formula reads C19H16ClNO4. The molecule contains 19 carbon atoms, 16 hydrogen atoms, one chlorine atom, one nitrogen atom, and four oxygen atoms. Its molecular weight is approximately 357.79 g/mol, which helps in accurate dosing and lab preparations. Key features include the indole ring and the chlorobenzoyl group. Manufacturers and chemists look closely at this structure when crafting formulations or seeking out similar compounds for research and development. Looking at this chemical layout, the careful relationship between components stands out; small shifts in arrangement can alter both effect and safety.
Indomethacin is neither volatile nor prone to rapid breakdown under normal conditions. Its density comes in around 1.38 g/cm3, placing it in line with many pharmaceutically active compounds. Melting happens at a temperature testifying to its stability, usually between 158°C to 162°C. The appearance is usually a fine crystalline solid; it does not present as liquid under ordinary storage or handling. In lab settings, one can see indomethacin in its pure crystalline form, but pharmaceutical production usually grinds it into powder or compresses it into solid forms, such as tablets. Occasionally, material scientists find value in recording granule sizes and compaction rates to guarantee batch consistency and safety in dosing, as inconsistent granulation might result in erratic absorption in patients.
In international trade, indomethacin gets assigned a Harmonized System Code—often listed under HS Code 2933.39, which covers heterocyclic compounds with nitrogen hetero-atom(s) only. This code eases customs classification and tax calculation during global shipment, which holds value for pharmaceutical companies exporting or importing drug ingredients. As a raw material, it falls within the ‘active pharmaceutical ingredients’ category, serving as both an essential building block for finished medicines and as a controlled item due to its pharmacological potency and safety considerations.
Dealing with indomethacin demands respect for chemical handling protocols. Inhalation, ingestion, or skin contact in large amounts—especially in raw material form—can be harmful, causing negative reactions ranging from mild irritation to more severe toxic effects, depending on exposure level. The compound rates as hazardous due to possible eye and respiratory irritation. Labs and pharmaceutical plants adopt personal protective equipment like gloves, masks, and eye shields, coupled with well-ventilated environments, during processing and handling. Waste management calls for careful practices since improper disposal introduces risk to both human health and the environment. Material safety data sheets spell out each potential hazard, outlining spill management and leak response. These steps do not only comply with regulatory law; they keep workplaces safe and communities healthy.
Indomethacin usually arrives as crystalline powder for lab use, though some specialists may see it processed into pearls for precise dosing, or suspended in solutions for intravenous application in hospital settings. Its water solubility sits on the low side; it dissolves better in alcohol, acetone, and certain organic solvents. This limited solubility drives pharmaceutical scientists to develop special formulations; some dissolve the chemical in solvents, while others apply coatings or create suspensions to improve uptake in the body. Tablet and capsule production processes put extra focus on particle size and blending to keep dosing accurate, reduce risk of uneven delivery, and promote patient safety. Compressing into tablets brings about further density and porosity questions, which can affect shelf life, degradation, and dissolution rate. Each method of preparing this material relates back to its critical raw physical and chemical features.
Indomethacin offers relief for millions with pain and inflammation, but with that benefit comes identifiable risks. Overexposure may lead to harmful outcomes—especially with improper handling of bulk material. Reports have linked workplace mishandling to skin, eye, and respiratory issues, and, in rare cases, to more lasting health effects when exposure persists without adequate safety measures. Regulatory oversight—such as safety training, clear labeling, and proper storage—returns proven reductions in reported incidents. Companies that foster safety cultures through regular audits, protective gear, ventilation upgrades, and continuous staff education see not only compliance with health laws but also higher worker satisfaction and fewer lost workdays. Advances in material science have enabled coated tablets, extended-release forms, or liquid suspensions that ease administration and improve safety. These practical, real-world shifts ensure that indomethacin remains both accessible and as safe as possible for the intended users—clinical professionals, patients, and workers in the supply chain.
